MedTech Special

AI drug discovery must deliver repeatable value beyond hype: Insilico Medicine’s Feng Ren

Feng Ren discusses AI’s impact on target discovery, R&D productivity and clinical development, and Asia’s role in translating computational predictions into new medicines....

Singlife and NHG Health partner to expand specialist care and advance value-based care

The collaboration focuses on digestive health, recovery and exploring bundled and fixed-rate care models to improve patient outcomes and healthcare sustainability....

Clinical judgement remains central to robotic surgery: Dr Catherine Teh

Dr Catherine Teh discusses how robotics, fluorescence imaging and clinician-led innovation can support complex liver surgery, and what wider adoption across Asia will require....

Longevity Medicine Must Move Beyond Hype to Evidence-Based Preventive Healthcare: Longevitix

Longevitix Co-Founders Effie Arditi and Dr Neil Panchal discuss the limitations of biological-age testing, the clinical promise of GLP-1 therapies, and how AI-powered continuous care, validated biomarkers and regulatory standards could reshape the future of healthy ageing....

Healthcare technology must be designed for scale, not just successful pilots

Dr Kamonlawan Chomchopbun of KPMG in Singapore, Dr May-Anne Cheong of SingHealth’s A.L.I.C.E. and Lars Wismer of Messe Düsseldorf Asia discuss why promising healthcare technologies struggle to move into routine care, what hospitals should measure before scaling, and how Southeast Asia can turn innovation into everyday implementation....

Asia must shift from treating illness to preventing disease: Kelvin Loh, AIA

Kelvin Loh, Group Chief Healthcare Officer at AIA, discusses how insurers, digital health, AI and behavioural science can help Asia's ageing populations live healthier lives while improving healthcare access and affordability....

AI can help imaging services do more with existing workforce and infrastructure: Ari Wood

Ari Wood, Acting Head of Imaging, Australia and New Zealand and Head of CT/AMI, Growth Region at Philips, discusses how AI-enabled MRI and CT technologies can address rising imaging demand, workforce constraints and regional access gaps across Australia and New Zealand....

AI MedTech’s Real Test Begins After FDA Clearance

Avenda Health’s Brittany Berry on bridging the reimbursement gap, proving economic value and turning AI innovation into sustainable commercial scale...

Glutamine Strategy Shows Early Promise in Extending Survival for Pancreatic Cancer

Cedars-Sinai’s Phase I GlutaPanc trial challenges conventional thinking around glutamine metabolism, with L-glutamine plus standard chemotherapy demonstrating encouraging survival and tumour-response signals in advanced pancreatic cancer....

Stryker Strengthens Peripheral Vascular Strategy With Amplitude Vascular Systems Acquisition

Deal Positions Stryker To Expand Into High Growth Intravascular Lithotripsy Segment And Address Complex Calcified Arterial Disease...